Annual Accounts Payable
$1.04 M
NaN%
December 1, 2023
Summary
- As of February 8, 2025, CAMP annual accounts payable is $1.04 million
- During the last 3 years, CAMP annual accounts payable has fallen by -$34.73 million (-97.09%).
- CAMP annual accounts payable is now -97.39% below its all-time high of $39.90 million, reached on February 28, 2019.
Performance
CAMP Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$3.87 M
+$2.41 M+165.09%
September 1, 2024
Summary
- As of February 8, 2025, CAMP quarterly accounts payable is $3.87 million, with the most recent change of +$2.41 million (+165.09%) on September 1, 2024.
- Over the past year, CAMP quarterly accounts payable has dropped by -$42.33 million (-91.62%).
- CAMP quarterly accounts payable is now -92.65% below its all-time high of $52.72 million, reached on February 28, 2023.
Performance
CAMP Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
CAMP Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -51.6% | -91.6% |
| 3 y3 years | -97.1% | -90.3% |
| 5 y5 years | -97.4% | -89.2% |
CAMP Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -97.1% | at low | -92.7% | +271.7% |
| 5 y | 5-year | -97.4% | at low | -92.7% | +271.7% |
| alltime | all time | -97.4% | +4.2% | -92.7% | +330.3% |
CAMP4 Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.87 M(+165.1%) |
| Jun 2024 | - | $1.46 M(+40.2%) |
| Dec 2023 | $1.04 M(-51.6%) | $1.04 M(-97.8%) |
| Nov 2023 | - | $46.70 M(+1.1%) |
| Aug 2023 | - | $46.21 M(-3.5%) |
| May 2023 | - | $47.90 M(-9.1%) |
| Feb 2023 | - | $52.72 M(+0.1%) |
| Dec 2022 | $2.15 M(-93.2%) | - |
| Nov 2022 | - | $52.67 M(+32.1%) |
| Aug 2022 | - | $39.86 M(+37.7%) |
| May 2022 | - | $28.95 M(-9.0%) |
| Feb 2022 | $31.82 M(-11.0%) | $31.82 M(+3.4%) |
| Nov 2021 | - | $30.78 M(+0.9%) |
| Aug 2021 | - | $30.52 M(+5.2%) |
| May 2021 | - | $29.00 M(-18.9%) |
| Feb 2021 | $35.77 M(+45.2%) | $35.77 M(-2.9%) |
| Nov 2020 | - | $36.83 M(+18.0%) |
| Aug 2020 | - | $31.21 M(-2.0%) |
| May 2020 | - | $31.84 M(+29.3%) |
| Feb 2020 | $24.64 M(-38.3%) | $24.64 M(-33.4%) |
| Nov 2019 | - | $36.99 M(-8.1%) |
| Aug 2019 | - | $40.27 M(+22.4%) |
| May 2019 | - | $32.89 M(-17.6%) |
| Feb 2019 | $39.90 M(+12.5%) | $39.90 M(+26.4%) |
| Nov 2018 | - | $31.56 M(-12.7%) |
| Aug 2018 | - | $36.16 M(-15.8%) |
| May 2018 | - | $42.94 M(+21.0%) |
| Feb 2018 | $35.48 M(+17.2%) | $35.48 M(-16.3%) |
| Nov 2017 | - | $42.40 M(+22.1%) |
| Aug 2017 | - | $34.72 M(+3.4%) |
| May 2017 | - | $33.59 M(+11.0%) |
| Feb 2017 | $30.27 M(+21.4%) | $30.27 M(-9.4%) |
| Nov 2016 | - | $33.39 M(-8.8%) |
| Aug 2016 | - | $36.60 M(+1.3%) |
| May 2016 | - | $36.14 M(+44.9%) |
| Feb 2016 | $24.94 M(+3.9%) | $24.94 M(+0.1%) |
| Nov 2015 | - | $24.92 M(-25.6%) |
| Aug 2015 | - | $33.50 M(+29.2%) |
| May 2015 | - | $25.93 M(+8.0%) |
| Feb 2015 | $24.01 M(+17.1%) | $24.01 M(-19.1%) |
| Nov 2014 | - | $29.70 M(+3.4%) |
| Aug 2014 | - | $28.73 M(+41.4%) |
| May 2014 | - | $20.31 M(-0.9%) |
| Feb 2014 | $20.51 M(+72.8%) | $20.51 M(+20.6%) |
| Nov 2013 | - | $17.00 M(-15.8%) |
| Aug 2013 | - | $20.19 M(+27.1%) |
| May 2013 | - | $15.88 M(+33.8%) |
| Feb 2013 | $11.87 M(+24.7%) | $11.87 M(-9.0%) |
| Nov 2012 | - | $13.05 M(-8.9%) |
| Aug 2012 | - | $14.32 M(-18.7%) |
| May 2012 | - | $17.62 M(+85.0%) |
| Feb 2012 | $9.52 M(-32.5%) | $9.52 M(-21.2%) |
| Nov 2011 | - | $12.08 M(-11.3%) |
| Aug 2011 | - | $13.62 M(-3.9%) |
| May 2011 | - | $14.18 M(+0.5%) |
| Feb 2011 | $14.10 M(-12.9%) | $14.10 M(-7.0%) |
| Aug 2010 | - | $15.16 M(+4.9%) |
| May 2010 | - | $14.46 M(-10.7%) |
| Feb 2010 | $16.19 M(+198.5%) | $16.19 M(+3.7%) |
| Nov 2009 | - | $15.61 M(+45.3%) |
| Aug 2009 | - | $10.75 M(+22.4%) |
| May 2009 | - | $8.78 M(+61.9%) |
| Feb 2009 | $5.42 M(-50.1%) | $5.42 M(-28.3%) |
| Nov 2008 | - | $7.56 M(-22.1%) |
| Aug 2008 | - | $9.71 M(-4.1%) |
| May 2008 | - | $10.13 M(-6.9%) |
| Feb 2008 | $10.88 M | $10.88 M(-1.0%) |
| Nov 2007 | - | $10.99 M(-22.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Aug 2007 | - | $14.18 M(-9.9%) |
| May 2007 | - | $15.74 M(-39.9%) |
| Feb 2007 | $26.19 M(+118.0%) | $26.19 M(+104.3%) |
| Nov 2006 | - | $12.82 M(-24.9%) |
| Aug 2006 | - | $17.08 M(-5.6%) |
| May 2006 | - | $18.09 M(+50.6%) |
| Feb 2006 | $12.01 M(-34.7%) | $12.01 M(-28.2%) |
| Nov 2005 | - | $16.72 M(+24.9%) |
| Aug 2005 | - | $13.38 M(-38.7%) |
| May 2005 | - | $21.84 M(+18.7%) |
| Feb 2005 | $18.39 M(+5.7%) | $18.39 M(-22.8%) |
| Nov 2004 | - | $23.83 M(+1.7%) |
| Aug 2004 | - | $23.43 M(+13.9%) |
| May 2004 | - | $20.57 M(+18.3%) |
| Feb 2004 | $17.39 M(+50.6%) | $17.39 M(+11.0%) |
| Nov 2003 | - | $15.67 M(+41.1%) |
| Aug 2003 | - | $11.11 M(+143.6%) |
| May 2003 | - | $4.56 M(-60.5%) |
| Feb 2003 | $11.55 M(+102.2%) | $11.55 M(+21.5%) |
| Nov 2002 | - | $9.51 M(+59.0%) |
| Aug 2002 | - | $5.98 M(-8.8%) |
| May 2002 | - | $6.56 M(+14.8%) |
| Feb 2002 | $5.71 M(+12.0%) | $5.71 M(-51.7%) |
| Nov 2001 | - | $11.83 M(+28.3%) |
| Aug 2001 | - | $9.22 M(+20.8%) |
| May 2001 | - | $7.63 M(+49.6%) |
| Feb 2001 | $5.10 M(-65.2%) | $5.10 M(-18.7%) |
| Nov 2000 | - | $6.28 M(+4.2%) |
| Aug 2000 | - | $6.03 M(-5.2%) |
| May 2000 | - | $6.36 M(-56.6%) |
| Feb 2000 | $14.66 M(+463.8%) | $14.66 M(+62.9%) |
| Nov 1999 | - | $9.00 M(+50.0%) |
| Aug 1999 | - | $6.00 M(+42.9%) |
| May 1999 | - | $4.20 M(+61.5%) |
| Feb 1999 | $2.60 M(+36.8%) | $2.60 M(+4.0%) |
| Nov 1998 | - | $2.50 M(+4.2%) |
| Aug 1998 | - | $2.40 M(+26.3%) |
| May 1998 | - | $1.90 M(0.0%) |
| Feb 1998 | $1.90 M(-9.5%) | $1.90 M(-26.9%) |
| Nov 1997 | - | $2.60 M(-36.6%) |
| Aug 1997 | - | $4.10 M(+46.4%) |
| May 1997 | - | $2.80 M(+33.3%) |
| Feb 1997 | $2.10 M(-34.4%) | $2.10 M(-12.5%) |
| Nov 1996 | - | $2.40 M(+4.3%) |
| Aug 1996 | - | $2.30 M(-36.1%) |
| May 1996 | - | $3.60 M(+12.5%) |
| Feb 1996 | $3.20 M(+28.0%) | $3.20 M(-5.9%) |
| Nov 1995 | - | $3.40 M(+54.5%) |
| Aug 1995 | - | $2.20 M(-37.1%) |
| May 1995 | - | $3.50 M(+40.0%) |
| Feb 1995 | $2.50 M(-34.2%) | $2.50 M(-10.7%) |
| Nov 1994 | - | $2.80 M(+55.6%) |
| Aug 1994 | - | $1.80 M(-33.3%) |
| May 1994 | - | $2.70 M(-28.9%) |
| Feb 1994 | $3.80 M(-17.4%) | $3.80 M(+40.7%) |
| Nov 1993 | - | $2.70 M(-15.6%) |
| Aug 1993 | - | $3.20 M(-30.4%) |
| Feb 1993 | $4.60 M(+76.9%) | $4.60 M(+70.4%) |
| Nov 1992 | - | $2.70 M(-6.9%) |
| Aug 1992 | - | $2.90 M(+45.0%) |
| May 1992 | - | $2.00 M(-23.1%) |
| Feb 1992 | $2.60 M(+160.0%) | $2.60 M(+62.5%) |
| Aug 1991 | - | $1.60 M(+33.3%) |
| May 1991 | - | $1.20 M(+20.0%) |
| Feb 1991 | $1.00 M(-16.7%) | $1.00 M(+11.1%) |
| Nov 1990 | - | $900.00 K(-18.2%) |
| Aug 1990 | - | $1.10 M(0.0%) |
| May 1990 | - | $1.10 M(-8.3%) |
| Feb 1990 | $1.20 M | $1.20 M |
FAQ
- What is CAMP4 Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for CAMP4 Therapeutics?
- What is CAMP4 Therapeutics annual accounts payable year-on-year change?
- What is CAMP4 Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for CAMP4 Therapeutics?
- What is CAMP4 Therapeutics quarterly accounts payable year-on-year change?
What is CAMP4 Therapeutics annual accounts payable?
The current annual accounts payable of CAMP is $1.04 M
What is the all time high annual accounts payable for CAMP4 Therapeutics?
CAMP4 Therapeutics all-time high annual accounts payable is $39.90 M
What is CAMP4 Therapeutics annual accounts payable year-on-year change?
Over the past year, CAMP annual accounts payable has changed by -$1.11 M (-51.56%)
What is CAMP4 Therapeutics quarterly accounts payable?
The current quarterly accounts payable of CAMP is $3.87 M
What is the all time high quarterly accounts payable for CAMP4 Therapeutics?
CAMP4 Therapeutics all-time high quarterly accounts payable is $52.72 M
What is CAMP4 Therapeutics quarterly accounts payable year-on-year change?
Over the past year, CAMP quarterly accounts payable has changed by -$42.33 M (-91.62%)